Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Exchange with Albumin in ALS
NCT02479802Phase 2Completed
- Sponsor
- Grifols
- Start
- Nov 2014
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of albumin (human) in amyotrophic lateral sclerosis (ALS), sponsored by Grifols. Started Nov 2014; status: completed.
02
Drugs
albumin (human)
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT02479802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02479802.